| Dr Andrew David Simkin, MD | |
|
3 Village Sq, Chelmsford, MA 01824-2712 | |
| (978) 256-4151 | |
| (978) 256-3987 |
| Full Name | Dr Andrew David Simkin |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 49 Years |
| Location | 3 Village Sq, Chelmsford, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730179623 | NPI | - | NPPES |
| 0120413 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 39025 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chelmsford Dermatology Pc | 0840266607 | 4 |
News Archive
Endo International plc and Auxilium Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which Endo will acquire all of the outstanding shares of common stock of Auxilium for a per share consideration of $33.25 in a cash and stock transaction.
As government support for personalized medicine grows, a consumer advocate, a patient, and bioethicists explore ethical controversies. Direct-to-consumer genetic tests, privacy, targeted cancer therapies, and Henrietta Lacks are among topics in a special issue of the Hastings center Report
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.
Testing cancers for 'addiction' to a gene that boosts cell growth can pick out patients who may respond to a targeted drug under development, a major new study reports.
› Verified 2 days ago
| Entity Name | Chelmsford Dermatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669463493 PECOS PAC ID: 0840266607 Enrollment ID: O20040903000065 |
News Archive
Endo International plc and Auxilium Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which Endo will acquire all of the outstanding shares of common stock of Auxilium for a per share consideration of $33.25 in a cash and stock transaction.
As government support for personalized medicine grows, a consumer advocate, a patient, and bioethicists explore ethical controversies. Direct-to-consumer genetic tests, privacy, targeted cancer therapies, and Henrietta Lacks are among topics in a special issue of the Hastings center Report
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.
Testing cancers for 'addiction' to a gene that boosts cell growth can pick out patients who may respond to a targeted drug under development, a major new study reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew David Simkin, MD 133 Salem St, Andover, MA 01810-2210 Ph: (978) 470-3340 | Dr Andrew David Simkin, MD 3 Village Sq, Chelmsford, MA 01824-2712 Ph: (978) 256-4151 |
News Archive
Endo International plc and Auxilium Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which Endo will acquire all of the outstanding shares of common stock of Auxilium for a per share consideration of $33.25 in a cash and stock transaction.
As government support for personalized medicine grows, a consumer advocate, a patient, and bioethicists explore ethical controversies. Direct-to-consumer genetic tests, privacy, targeted cancer therapies, and Henrietta Lacks are among topics in a special issue of the Hastings center Report
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.
Testing cancers for 'addiction' to a gene that boosts cell growth can pick out patients who may respond to a targeted drug under development, a major new study reports.
› Verified 2 days ago
Dr. Khalil A Khatri, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6 Courthouse Ln Unit 7, Chelmsford, MA 01824 Phone: 978-453-5559 Fax: 978-453-4459 | |
Rafael A Pupo, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 228 Billerica Rd, Chelmsford, MA 01824 Phone: 978-250-6010 Fax: 978-244-6610 | |
Dr. Caroline Bevona, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 228 Billerica Rd, Chelmsford, MA 01824 Phone: 978-250-6010 Fax: 978-244-6610 | |
Dr. Christine M Hayes, MD Dermatology Medicare: May Accept Medicare Assignments Practice Location: 33 Village Sq, Chelmsford, MA 01824 Phone: 978-244-0060 Fax: 978-244-2522 | |
Dr. Michael Thomas Rosenbaum, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6 Courthouse Ln, Chelmsford, MA 01824 Phone: 978-934-9294 Fax: 978-934-0056 |